Insulin Pens, Muscle Relaxants Prominent on New FDA Watch List Insulin Pens, Muscle Relaxants Prominent on New FDA Watch List

The updates alert physicians to new safety information or possible signs of serious risk with a drug or drug class. Making the list, however, does not mean that the FDA has determined that a drug has the risk.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
More News: Health | Insulin | Primary Care